Article

jdsupra.com on 2023-04-04 15:32

[Audio] Reissue in IPR and PGR Practice – Patents: Post-Grant Podcast

Please join Troutman Pepper’s Intellectual Property and Health Sciences practice groups for our podcast series, which focuses on strategies, trends, ...

Related news

[Audio] Reissue vs. Reexamination in IPR and PGR Practice - Patents: Post-Grant Podcast jdsupra.com
Legislative Update – STRONG Patents Act Takes Aim at IPR and PGR jdsupra.com
[Audio] UPSTO Director Review — Patents: Post-Grant Podcast jdsupra.com
[Audio] Knocking Out an IPR Institution Early jdsupra.com
Mylan Files New IPR Petitions on Aflibercept Patents jdsupra.com
Celltrion and Samsung File IPR Petitions on Aflibercept Patents jdsupra.com
Celltrion Files Petitions for IPR of Three Rituximab Patents jdsupra.com
[Audio] Behaving Badly: OpenSky v. VLSI and Sanctions at the PTAB — Patents: Post-Grant Podcast jdsupra.com
Estoppel After Final Written Decisions in IPR and PGR Proceedings jdsupra.com
PTAB Finalizes “Quick Fix” Changes to IPR/PGR Procedure jdsupra.com
Forum Selection Clause Prohibits Filing IPR and PGR Petitions jdsupra.com
California , United States , Switzerland
Reverse Engineered Search Insufficient For IPR/PGR Estoppel jdsupra.com
East Bay
Another Example of Practical Estoppel in IPR Practice jdsupra.com
30 Months of IPR Practice – By the Numbers jdsupra.com
Wall Street
Board Grants Hospira Mixed Results on its Five Petitions for IPR of Genentech’s Trastuzumab Patents jdsupra.com
Kyle Bass Loses Round 1 of IPR Attack Against Pharma/Biotech Patents jdsupra.com
Dallas , United States
Fresenius files IPR petitions challenging Chugai/Roche/Genentech rheumatoid arthritis patents jdsupra.com
Celltrion Files Two Additional Petitions for IPR on Genentech’s Trastuzumab Patents jdsupra.com
Celltrion Files Two Additional Petitions for IPR of Genentech’s Trastuzumab Patents jdsupra.com